노스캐롤라이나의 암 (전체) 임상 시험
암 (전체) 관련 연구 92개가 노스캐롤라이나 내 여러 지역에서 참여자를 모집하고 있습니다.
노스캐롤라이나의 도시
공식 연구 텍스트(영어)
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Messino Cancer Centers Asheville, Asheville
- Duke University Medical Center Duke Cancer Center, Durham
- FirstHealth Cancer Center, Pinehurst
피험자 모집 중3상
18세 ~ 100세 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT05920356Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic Syndromes
- University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT07672769Feasibility Pilot of AYA-PARTNER
- University of North Carolina at Chapel Hill, Chapel Hill
피험자 모집 중
18세 ~ 39세 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07829146A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
- University of North Carolina /ID# 251203, Chapel Hill
- Atrium Health Wake Forest Baptist Medical Center /ID# 251165, Winston-Salem
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT05650632RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of North Carolina at Chapel Hill, Chapel Hill
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT07002034Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Duke University Medical Center, Durham
- Duke Women's Cancer Care Raleigh, Raleigh
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT06580314Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- East Carolina University, Greenville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT07195591A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- University of North Carolina at Chapel Hill, Chapel Hill
- Duke University Medical Center - Duke Cancer Centre, Durham
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06901531Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC
- Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, Chapel Hill
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06096038A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
- Oncology Specialists of Charlotte, Charlotte
- Southern Oncology Specialists, Huntersville
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07169851A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
- Levine Cancer Institute, Charlotte
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06150157Distance-Based Exercise to Preserve Function and Prevent Disability
- Novant Health Cancer Institute - Kernersville, Kernersville
- Novant Health Cancer Institute - Mount Airy, Mount Airy
- Novant Health Forsyth Medical Center, Winston-Salem
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07059884A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- University of North Carolina Medical Center, Chapel Hill
- Duke Cancer Institute, Durham
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06119581Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
- Atrium Health Carolinas Medical Center, Charlotte
- Duke Health - Duke University Hospital, Durham
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT05856981Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- The University of North Carolina at Chapel Hill, Chapel Hill
- Levine Cancer Institute, Charlotte
- Duke University Medical Center, Durham
- 외 1개
피험자 모집 중2/3상
전 연령 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT03435796A Study of ARC-02 in B-cell NHL
- Levine Cancer Institute, Charlotte
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT07691606A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)
- GSK Investigational Site, Durham
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT06796907Young Adult Infusion Space Experience Satisfaction Survey
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
피험자 모집 중관찰 연구
18세 ~ 39세 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT05720546Improving Adherence to Chronic Disease Medication Regimens Among Patients With Recently Diagnosed Cancer
- Duke University, Durham
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT07811258Keep Social Randomized Controlled Trial for Young Adults With Cancer
- University of North Carolina at Chapel Hill, Chapel Hill
피험자 모집 중
22세 ~ 39세 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT07788339Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- University of North Carolina at Chapel Hill, Chapel Hill
피험자 모집 중3상
18세 ~ 71세 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT07504458A Study of LP-118 In Combination With Ponatinib, Dexamethasone And Blinatumomab For Adults With Newly-Diagnosed, BCR::ABL1-Positive Acute Lymphoblastic Leukemia (ALL)
- Atrium Health Levine Cancer, Charlotte
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 29. 업데이트됨 · NCT07614022Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill
피험자 모집 중관찰 연구
18세 ~ 120세 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT01137643Comprehensive Care for AYA: Needs Assessment Survey
- Atrium Health Levine Cancer, Charlotte
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
피험자 모집 중관찰 연구
15세 이상 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT07196241Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer
- FirstHealth Cancer Center, Pinehurst
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT05168566A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
- Atrium Health Levine Cancer Institute /ID# 271510, Charlotte
- University Of North Carolina Health Care - Hillsborough Campus /ID# 272454, Hillsborough
- Atrium Health Wake Forest Baptist Medical Center /ID# 271294, Winston-Salem
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT06953960Study of the Effect of Innate on the Inflammatory Response to Endotoxin
- NIEHS Clinical Research Unit (CRU), Research Triangle Park
피험자 모집 중관찰 연구건강한 지원자 환영
18세 ~ 100세 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT01143480A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- Research Site, Durham
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT06835569Neurocognitive Trajectories After BCMA CAR-T
- Atrium Health Levine Cancer, Charlotte
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT07740317Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- Durham VA Medical Center, Durham, NC, Durham
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT02984761UNC Pleural Fluid Registry
- UNC Lingeberger Comprehensive Cancer Center, Chapel Hill
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT05620329A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- Duke Cancer Center, Durham
피험자 모집 중1상
18세 이상 · 남성 · 2026. 10. 20. 업데이트됨 · NCT07103018A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
- University of North Carolina at Chapel Hill /ID# 274667, Chapel Hill
- Atrium Health Levine Cancer Institute /ID# 276193, Charlotte
- Atrium Health Wake Forest Baptist Medical Center /ID# 274847, Winston-Salem
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 19. 업데이트됨 · NCT06892522A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill
- Levine Cancer Institute, Charlotte
- University of North Carolina Hospitals at Hillsborough, Hillsborough
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 10. 14. 업데이트됨 · NCT06989437A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Research Site, Charlotte
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT05123482Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- Carolina BioOncology Institute, Huntersville
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT06993844A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- Duke University Medical Center /ID# 279457, Durham
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT07023289FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Duke University, Durham
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 7. 업데이트됨 · NCT05919264CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Duke University Medical Center, Duke Cancer Center, Durham
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 6. 업데이트됨 · NCT03328078A Study of PHN-012 in Patients With Advanced Solid Tumors
- PHN-012-001 Site, Durham
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07127874ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.